Related Experiment Video
Updated: Apr 28, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitis
Tamazoust Guiddir, Ala-Eddine Deghmane, Dario Giorgini
1Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci, 28 Rue du Dr Roux, 75724 Paris, Cedex 15, France. mktaha@pasteur.fr.
Background:
Early differential diagnosis between acute bacterial and viral meningitis is problematic. We aimed to investigate whether the detection of lipocalin 2, a protein of the acute innate immunity response, may be used as a marker for acute bacterial meningitis.
Methods:
Transgenic mice expressing the human transferrin were infected by intraperitoneal route and were imaged. Cerebrospinal fluid (CSF) was sampled up to 48hours post- infection to measure lipocalin 2. We also tested a collection of 90 and 44 human CSF with confirmed acute bacterial or acute viral meningitis respectively.
Results:
Lipocalin 2 was detected after 5 h in CSF during experimental infection in mice. Lipocalin 2 levels were significantly higher (p < 0.0001) in patients with confirmed acute bacterial meningitis (mean 125 pg/mL, range 106-145 pg/mL) than in patients with acute viral meningitis (mean 2 pg/mL, range 0-6 pg/mL) with a sensitivity of 81%, a specificity of 93%, a positive predictive value of 96% and a negative predictive value of 71% in diagnosing acute bacterial meningitis.
Conclusions:
Increased levels of lipocalin 2 in cerebrospinal fluid may discriminate between acute bacterial and viral meningitis in patients with clinical syndrome of meningitis.
Insights
Lipocalin 2 shows promise as a biomarker for bacterial meningitis. Elevated levels in cerebrospinal fluid can help differentiate bacterial from viral meningitis, aiding early diagnosis.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Distinguishing between acute bacterial and viral meningitis is clinically challenging.
- Lipocalin 2, a protein involved in innate immunity, is explored as a potential diagnostic marker.
Purpose of the Study:
- To evaluate lipocalin 2's efficacy in differentiating acute bacterial meningitis from viral meningitis.
- To assess lipocalin 2 as a biomarker in cerebrospinal fluid (CSF).
Main Methods:
- Experimental meningitis was induced in transgenic mice, with CSF lipocalin 2 levels monitored post-infection.
- Human CSF samples from patients with confirmed bacterial (n=90) or viral (n=44) meningitis were analyzed for lipocalin 2.
Main Results:
- Lipocalin 2 was detected in mouse CSF within 5 hours of infection.
- Significantly higher lipocalin 2 levels were observed in bacterial meningitis patients (mean 125 pg/mL) compared to viral meningitis patients (mean 2 pg/mL).
- Diagnostic performance included 81% sensitivity, 93% specificity, 96% positive predictive value, and 71% negative predictive value for bacterial meningitis.
Conclusions:
- Elevated lipocalin 2 concentrations in CSF can effectively distinguish between acute bacterial and viral meningitis.
- Lipocalin 2 serves as a valuable biomarker for diagnosing bacterial meningitis in patients presenting with meningitis symptoms.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

